For example, histone lysine side-chain acetylation increased by c-myc can be effectively suppressed by inhibition of acetyl-lysine recognition domains (bromodomains) in multiple myeloma, a Myc-dependent hematologic cancer (130). This evidence concerns the gene MYC and hematopoietic and lymphoid cell neoplasm.